Registration Dossier
Registration Dossier
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 235-111-5 | CAS number: 12069-32-8
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data

Acute Toxicity: oral
Administrative data
- Endpoint:
- acute toxicity: oral
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- March 03 - April 23, 2010
- Reliability:
- 1 (reliable without restriction)
Data source
Reference
- Reference Type:
- study report
- Title:
- Unnamed
- Year:
- 2 010
- Report date:
- 2010
Materials and methods
Test guidelineopen allclose all
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 423 (Acute Oral toxicity - Acute Toxic Class Method)
- Deviations:
- no
- Qualifier:
- according to guideline
- Guideline:
- EPA OPPTS 870.1100 (Acute Oral Toxicity)
- Deviations:
- no
- Qualifier:
- according to guideline
- Guideline:
- other: Commission Regulation (EC) No. 440/2008,L 142, Annex Part B, 30 May 2008
- Deviations:
- no
- Qualifier:
- according to guideline
- Guideline:
- other: EPA OPPTS 870.1000 (Acute toxicity testing background)
- Deviations:
- no
- GLP compliance:
- yes (incl. QA statement)
- Remarks:
- GLP according to German Chemikaliengesetz and Directive 2004/9/EC
- Test type:
- acute toxic class method
- Limit test:
- yes
Test material
- Reference substance name:
- Boron carbide
- EC Number:
- 235-111-5
- EC Name:
- Boron carbide
- Cas Number:
- 12069-32-8
- Molecular formula:
- CB4
- IUPAC Name:
- 2,3,4,5-tetraboratetracyclo[2.1.0.0¹,³.0²,⁵]pentane
- Details on test material:
- Boron carbide, powder, technical grade, purity 97%, trade name: TETRABOR , batch no. 908M1300, supplied by ESK Ceramics GmbH & Co. KG
Constituent 1
Test animals
- Species:
- rat
- Strain:
- Wistar
- Sex:
- female
- Details on test animals or test system and environmental conditions:
- Species/strain: Healthy rats, WISTAR rats Crl: WI(Han) (Full-Barrier)
Source: Charles River, 97633 Sulzfeld, Germany
Sex: female, non-pregnant, nulliparous
Age at the beginning of the study: 9 - 10 weeks old
Body weight at the beginning of the study:
Animals no. 1 - 3, step 1: 157 - 164 g;
Animals no. 4 - 6, step 2: 166 - 178 g;
The animals were derived from a controlled full barrier maintained breeding system (SPF).
Housing and Feeding Conditions
- Full-barrier in an air-conditioned room
- Temperature: 22 ± 3°C
- Relative humidity: 55 ± 10%
- Artificial light, sequence being 12 hours light, 12 hours dark
- Air change: 10 x / hour
- Free access to Altromin 1324 maintenance diet for rats and mice (lot no. 1310)
- Free access to tap water, sulphur acidified to a pH value of approx. 2.8 (drinking water, municipal residue control, microbiological control at regular
intervals)
- The animals were kept in groups in IVC cages, type III H, polysulphone cages on Altromin saw fibre bedding (lot no. 040509)
- Certificates of food, water and bedding are filed at BSL BIOSERVICE
- Adequate acclimatisation period (at least five days).
Administration / exposure
- Route of administration:
- oral: gavage
- Vehicle:
- cotton seed oil
- Remarks:
- (Sigma, lot no. 038K0009, expiry date: 1110412010
- Details on oral exposure:
- Prior to the administration a detailed clinical observation was made of all animals.
Prior to the administration food was withheld from the test animals for 16 to 19 hours (access to water was permitted). Following the period of fasting the animals were weighed and the test item was administered. Food was provided again approximately 4 hours post dosing.
For all animals of the first and second step, 2 g of the test item were suspended in the vehicle to gain a final volume of 10 ml and to achieve a dose of 2000 mg/kg body weight at a dose volume of 10 ml/kg body weight. The dose formulations were made shortly before each dosing occasion.
The test item was administered at a single dose by gavage using a feeding tube. - Doses:
- 2000 mg/kg bw
- No. of animals per sex per dose:
- 3 females per dose per step
- Control animals:
- no
- Details on study design:
- Duration of observation period following administration: 14 days
- Frequency of observations and weighing:
A careful clinical examination was made several times on the day of dosing (at least once during the first 30 minutes and with special attention given during the first 4 hours post-dose). As soon as symptoms were noticed they were recorded. Thereafter, the animals were observed for clinical signs once daily until the end of the observation period. All abnormalities were recorded.
The animals were weighed on day 1 (prior to the administration) and on days 8 and 15.
- Necropsy of survivors performed: yes
- Other examinations performed:
- Cageside observations included changes in the skin and fur, eyes and mucous membranes. Also respiratory, circulatory, autonomic
and central nervous systems and somatomotor activity and behaviour pattern were examined. Particular attention was directed to
observations of tremor, convulsions, salivation, diarrhoea, lethargy, sleep and coma.
- body weight
- gross necropsy: All gross pathological changes were recorded. - Statistics:
- Not relevant due to no toxic effects observed in Limit test
Results and discussion
- Preliminary study:
- Not applicable
Effect levels
- Sex:
- female
- Dose descriptor:
- LD50
- Effect level:
- > 2 000 mg/kg bw
- Based on:
- test mat.
- Remarks on result:
- other: no mortalities, Limit Test
- Mortality:
- No intercurrent deaths (see table 1)
- Clinical signs:
- other: other: No signs of toxicity observed (see table 2)
- Gross pathology:
- No abnormalities detected (see table 4)
Any other information on results incl. tables
Table 1: Results per Step
Step | Sex/no. | Dose (mg/kg) | Number of animals | Number of intercurrent deaths |
1 | female/ 1-3 | 2000 | 3 | 0 |
2 | female/ 4-6 | 2000 | 3 | 0 |
Table 1: LD50 cut off
Dose (unit) | Number of animals investigated | Number of intercurrent deaths | LD50 cut off |
2000 mg/kg bodyweight | 6 | 0 | unclassified |
Table 2: Clinical Signs - Individual Data
Animal no. /sex | Time of observation post-dose | Observations |
1/female | during the whole observation period | no signs of toxicity |
2/female | during the whole observation period |
no signs of toxicity |
3/female | during the whole observation period |
no signs of toxicity |
4/female | during the whole observation period |
no signs of toxicity |
5/female | during the whole observation period |
no signs of toxicity |
6/female | during the whole observation period |
no signs of toxicity |
Table 3: Absolute Body Weights in g and Body Weight Gain in %
Animal no. /sex | g Day 1 | g Day 8 | g Day 15 | % Day 1-15 |
1 /female | 157 | 188 | 197 | 26 |
2 /female | 164 | 194 | 200 | 22 |
3/female | 162 | 179 | 189 | 17 |
4 /female | 166 | 182 | 184 | 11 |
5 /female | 178 | 207 | 205 | 15 |
6/female | 169 | 191 | 195 | 15 |
Table 4:Macroscopical Findings - Individual Data
Animal no./sex | Organ | Findings at the necropsy |
1 /female | - | NAD |
2 /female | - | NAD |
3/female | - | NAD |
4 /female | - | NAD |
5 /female | - | NAD |
6/female | - | NAD |
NAD: No Abnormalities Detected
Applicant's summary and conclusion
- Interpretation of results:
- not classified
- Conclusions:
- Under the conditions of the present study, single oral application of the test item Boron Carbide B4C to rats at a dose of 2000 mg/kg body weight was associated with no signs of toxicity or mortality.
The median lethal dose of Boron Carbide B4C after single oral administration to female rats, observed over a period of 14 days is: LD50 cut off (rat): unclassified
In conformity with the criteria given in Annex VI to Commission Directive 2001/591 EC the test item Boron Carbide B4C has no obligatory labelling requirement for toxicity.
According to Annex I of Regulation (EC) 1272/2008 the test item Boron Carbide B4C was unclassified.
According to OECD-GHS (Globally Harmonized Classification System) the test item Boron Carbide B4C has no obligatory labelling requirement for toxicity. - Executive summary:
Two groups, each of three female WISTAR Crl: WI(Han) rats, were treated with the test item by oral gavage administration at a dosage of 2000 mg/kg body weight. The test item was suspended in a vehicle (cottonseed oil) at a concentration of 0.2 g/ml- and administered at a dose volume of 10 ml/kg. All animals after their entrance at BSL were allowed to acclimatise to the laboratory conditions for at least 5 days. The animals were observed on delivery, on inclusion in the study and before administration for mortality/morbidity and other clinical signs. All animals were examined for clinical signs several times on the day of dosing and once daily until the end of the observation period. Their body weights were recorded on day 1 (prior to the administration) and on days 8 and 15. All animals were necropsied and examined macroscopically. All animals survived until the end of the study without showing any signs of toxicity. Throughout the 14-day observation period, the weight gain of the animals was within the expected range. At necropsy, no macroscopical findings were observed in any animal of any step. On the basis of the test results given below and in conformity with the criteria given in Annex VI to Commission Directive 2001/591EC as well as in Annex I of Regulation (EC) 1272/2008, the substance should be not classified.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.
